HOME >> BIOLOGY >> NEWS
Emory University Fragile X Group Receives NIH Program Grant

The team will seek clues to the mechanisms of the triple-repeat expansion and the suppression of FMRP during transcription as well as the role of FMRP on protein translation and the consequence of its absence on protein synthesis in neurons in specific regions of the brain and spine. They will develop model systems, including one to investigate yeast genes that express proteins similar to FMRP, and a new generation of FMR1 knockout mice in which they can closely control FMRP expression, both pre- and postnatally, through drug exposure. The investigators also will address fundamental questions relating to possible future therapeutic strategies.

Stephen T. Warren, Ph.D., is the only Howard Hughes Medical Institute (HHMI) Investigator in the State of Georgia. The HHMI, located in Chevy Chase, MD, was founded in 1953 by the aviator-industrialist, Howard R. Hughes. It is a scientific and philanthropic organization whose primary purpose is conducting biomedical research.

Currently there are more than 330 Howard Hughes Medical Institute investigators. Widely recognized for their creativity and productivity, they include several Nobel Prize winners and more than 50 members of the National Academy of Sciences. The scientists are employed by HHMI and conduct their work at HHMI facilities at leading research institutions nationwide under collaborative relationships with those institutions.

Through its Grants Program, HHMI supports the research of outstanding biomedical scientists in selected countries outside the United States. These International Research Scholars are located in nations as diverse as Mexico, Australia and the former Soviet Republics. In conjunction with the National Institutes of Health (NIH), the Institute maintains the Research Scholars Program, which provides research opportunities for selected medical students in the laboratories of NIH scientists.


'"/>

Contact: Holly Korschun
hkorsch@emory.edu
404/727-3990
Emory University Health Sciences Center
26-Jan-1998


Page: 1 2 3

Related biology news :

1. Emory researchers map structure of anti-cancer molecule
2. Hope Clinic of Emory Vaccine Center receives CDC contract
3. Emory scientists receive NIH MIDAS grant for computer modeling of infectious diseases
4. Emory researchers develop model to track the evolution of emerging infectious diseases
5. Emory scientists use enzymes to enhance regeneration of damaged peripheral nerves in mice
6. Emory scientists track down immune sentinel cells with gene gun
7. Emory researchers discover novel mechanism of how anthrax impairs immunity
8. Emory scientists find anti-tumor compounds in magnolia cones
9. Emorys CancerQuest wins top Web award from Scientific American
10. Emory University researchers uncover novel self-assembly of Alzheimers amyloid fibrils
11. Emory Vaccine Research Center study identifies specific gene required for long-term immunity

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/30/2019)... ... September 30, 2019 , ... ... molecular manufacturing and other transformative technologies, announced the winners for the 2019 Foresight ... the other for Theory in nanotechnology/molecular manufacturing. , Established in 1993 and named ...
(Date:9/30/2019)... ... ... As human induced pluripotent stem cells (hiPSCs) move closer to becoming a ... the human heart, there is an increasing need for stable stem cell lines that ... and easily recorded. A study released today in STEM CELLS details the development of ...
(Date:9/30/2019)... Calif. (PRWEB) , ... September ... ... a leading think tank, research, and public interest organization focused on molecular ... Distinguished Student Prize. , The Award recognizes the College graduate or undergraduate ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... , ... October 02, 2019 , ... ... life sciences leadership firm that is enabling clinical program outsourcing success by cultivating ... by award-winning pharma and biotech veteran executive Brenda Reese, phaseUP™ brings clients deep, ...
(Date:10/3/2019)... BOSTON (PRWEB) , ... October 03, 2019 , ... Yesterday, ... 2-3, Asymmetrex founder and director, James L. Sherley, M.D., Ph.D., discussed important ... To an attendee audience including both developers and suppliers of clinical trials, in ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and ... company focused on the development of therapies to treat central nervous system ...
(Date:9/22/2019)... ... 20, 2019 , ... ZRT Laboratory is pleased ... serum . BDNF plays a vital role in protecting existing neurons in the ... neurons in the brain involved in learning, memory, and higher thinking. Low serum ...
Breaking Biology Technology:
Cached News: